arrow
C

Chuanxu Liu

fudan university
H指数:15
被引数:1,097

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world treatment patterns and outcomes of brentuximab vedotin–based therapy in CD30-positive lymphomas in China: the prospective BRAVE study

中国CD30阳性淋巴瘤中基于 Brentuximab vedotin 的治疗模式与疗效:前瞻性 BRAVE 研究

2026-09-300
OA
Novel noscapine derivative induces AML differentiation by dual-engaging DHODH and mitochondrial lipids to trigger a metabolic–epigenetic–transcriptional cascade

新型那可丁衍生物通过双重靶向DHODH和线粒体脂质触发代谢-表观遗传-转录级联以诱导急性髓系白血病分化

2026-05-220
OAAI